Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Recruiting now · Phase 3

Conditions studied: Hemophilia A, Hemophilia B

In brief

A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participant visits will be based on standard of care.

Key facts

Study ID

NCT05568719

Run by

Pfizer

People needed

173

Starts

2022-12-28

Expected to finish

2040-02-25

Last updated by the study team

2026-05-27

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Only participants who received investigational giroctocogene fitelparvovec or fidanacogene eleparvovec and were enrolled in a Pfizer-sponsored study (C0371002, C0371003, C0371005, C3731001, C3731003) are eligible.

You may not qualify if…

• None

Where it is running

• The Regents of the University of California||UC Davis Health — Rancho Cordova, California, United States (enrolling)
• UC Davis Health — Sacramento, California, United States (enrolling)
• UC Davis Ambulatory Care Clinic — Sacramento, California, United States (enrolling)
• UC Davis Hemophilia Treatment Center — Sacramento, California, United States (enrolling)
• UC Davis Medical Center — Sacramento, California, United States (enrolling)
• USF Health Morsani Center For Advanced Healthcare — Tampa, Florida, United States (enrolling)
• The University of South Florida Board of Trustees — Tampa, Florida, United States (enrolling)
• Cornell University||Joan & Sanford I. Weill Medical College — New York, New York, United States (enrolling)
• Weill Cornell Medical College-New York Presbyterian Hospital — New York, New York, United States (enrolling)
• The Childrens Hospital of Philadelphia Division of Hematology — Philadelphia, Pennsylvania, United States (enrolling)
• The Childrens Hospital of Philadelphia Division of Hematology — Philadelphia, Pennsylvania, United States (enrolling)
• Royal Prince Alfred Hospital — Camperdown, New South Wales, Australia (enrolling)
• Sydney Local Health District (RPAH Zone) — Camperdown, New South Wales, Australia (enrolling)
• Ege Universitesi Hastanesi — Izmir, İ̇zmir, Turkey (Türkiye) (enrolling)
• UCSF Outpatient Hematology Clinic — San Francisco, California, United States
• National Taiwan University Hospital — Taipei, Taiwan
• Acibadem Adana Hospital — Adana, Turkey (Türkiye)
• Mississippi Center For Advanced Medicine — Madison, Mississippi, United States
• Unity Health Toronto, St. Michael's Hospital — Toronto, Ontario, Canada
• Kyung Hee University Hospital at Gangdong — Seoul, South Korea
• Skåne University Hospital — Malmö, Sweden
• Taichung Veterans General Hospital — Taichung, Taiwan
• Washington Institute for Coagulation — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.